The case centers on the accessibility of mifepristone, the only drug approved specifically for terminating pregnancies, and whether the government applied a lawful review process of the drug when it first came out.
The Supreme Court has the potential to radically restrict access to this pill, says Mary Ziegler, a law professor at the University of California at Davis with an expertise in abortion.
[
add
]
[
|
|
...
]